Cytomid 250mg

Cytomid 250 is a medication used to treat prostate cancer, specifically advanced prostate cancer. It is an oral medication that works by blocking the production of dihydrotestosterone (DHT), a hormone that can stimulate the growth of cancer cells. Here are some key points about the product:

Composition:

Cytomid 250 contains Flutamide, a medication that blocks the production of DHT in the body.

Indications:

Cytomid 250 is indicated for the treatment of:

1. Advanced prostate cancer in patients who have not responded to other treatments
2. Prostate cancer in patients who have undergone orchiectomy (surgical removal of the testicles)

Mechanism of Action:

Flutamide works by:

1. Binding to androgen receptors in the prostate gland, which prevents the binding of DHT and reduces the growth of cancer cells
2. Reducing the production of DHT, which is produced by the enzyme 5-alpha-reductase

Dosage and Administration: The recommended dosage of Cytomid 250 is:

• 1 tablet (250mg) taken orally three times daily, with or without food
• The dose should be taken at the same time each day
• The medication should be taken continuously until disease progression or unacceptable toxicity

Side Effects:

Common side effects of Cytomid 250 include:

1. Gynecomastia (breast enlargement)
2. Hot flashes
3. Fatigue
4. Nausea and vomiting
5. Diarrhea
6. Abdominal pain
7. Increased risk of liver damage

Serious side effects can include:

1. Hepatotoxicity (liver damage)
2. Pancreatitis (inflammation of the pancreas)
3. Severe allergic reactions
4. Anaphylaxis (a severe allergic reaction)

Contraindications:

Cytomid 250 is contraindicated in patients with:

1. Hypersensitivity to Flutamide
2. Pregnancy or breastfeeding
3. Severe liver or kidney disease
4. Active bleeding or bleeding disorder

Precautions:

1. Patients with a history of liver or kidney disease should be closely monitored while receiving Cytomid 250.
2. Patients with a history of bleeding or bleeding disorders should be closely monitored while receiving Cytomid 250.
3. Patients with a history of liver damage should be closely monitored while receiving Cytomid 250.

Patient Counseling:

• Patients should be counseled on the importance of taking their medication as directed and not missing doses.
• Patients should be instructed to report any signs of gynecomastia or breast enlargement.
• Patients should be advised to report any changes in their appetite or weight loss.

Storage and Handling:

• Store at room temperature (20°C to 25°C) and protected from light.
• Do not freeze or expose to direct sunlight.
• Use within 24 months of opening.

Please note that the dosage and administration information is based on the recommended dosage and may vary depending on individual patient needs and circumstances.